|
...a few things....competitors, including Hyalgan, are lower molecular wt, so less viscus, so shorter acting/less effective..it is this cross polymerization causing higher viscosity that is the strength of BIOX patents...cost in US will be 300-$500 for 3 injections, which is Hyalgan price for 5 injections...Wyeth sales drive will materialize within a month after big sales meeting in the next few weeks....my understanding is that this is being targeted as a potential billion $ drug, of which 30-40% would flow to BIOX...as a company with 8 mil sh out, 4 mil of which are closely held, and probably not a one drug co, with Hyalform (wrinkles) and others closer, with only one firm covering it on the street, and rather thin for real money to buy big, expect volatility, but expect a monster up move with operational earnings visibilty over the next few qtrs..at this price, would buy whatever is close to a full position, addind if pulls back...as always, IMHO |
